XML 72 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Sep. 29, 2012
OPERATING ACTIVITIES      
Net income (loss) $ 17.3 $ (1,172.8) $ (73.6)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation 94.7 95.5 71.9
Amortization 428.5 420.5 273.9
Non-cash interest expense 68.7 81.2 75.0
Stock-based compensation expense 50.0 52.3 40.6
Excess tax benefit related to equity awards (5.7) (7.4) (6.2)
Deferred income taxes (243.1) (198.0) (155.2)
Gain on sale of intellectual property 0 (53.9) (12.4)
Fair value adjustments to contingent consideration 0 11.3 38.5
Fair value write-up of inventory sold 0 52.4 19.9
Impairment of goodwill 0 1,117.4 5.8
Asset impairment charges 38.4 9.4 16.9
Acquired in-process research and development 0 0 4.5
Debt extinguishment losses (7.4) (9.2) (42.3)
Cost-method equity investment impairment charges 6.9 6.4 0
Gain on sale of cost-method equity investment 0 (2.0) 0
Loss on disposal of property and equipment 7.1 4.9 3.8
Loss on sale of businesses 5.5 0 0
Other (11.8) 2.9 (3.7)
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable 7.9 4.1 (11.0)
Inventories (44.7) 25.2 (12.2)
Prepaid income taxes 22.4 25.1 6.1
Prepaid expenses and other assets 17.3 0.9 69.8
Accounts payable 11.8 (6.4) 3.8
Accrued expenses and other liabilities 14.7 2.3 (41.0)
Deferred revenue 15.1 13.3 12.7
Net cash provided by operating activities 508.4 493.8 370.2
INVESTING ACTIVITIES      
Acquisition of businesses, net of cash acquired 0 (6.3) (3,762.4)
Payment of additional acquisition consideration 0 (16.8) (9.8)
Proceeds from sale of business, net of cash transferred 10.1 85.1 0
Purchase of property and equipment (44.3) (49.0) (33.1)
Increase in equipment under customer usage agreements (35.9) (41.1) (45.6)
Net sales (purchases) of insurance contracts 13.8 (4.0) 0
Purchases of mutual funds (29.7) 0 0
Sales of mutual funds 22.4 0 0
Proceeds from sale of intellectual property 0 60.0 12.5
Acquisition of in-process research and development assets 0 0 (4.5)
Purchase of cost-method equity investments 0 (3.7) (0.3)
Sale of a cost-method equity investment 0 2.1 0
Increase in other assets (3.4) (7.5) (7.6)
Net cash (used in) provided by investing activities (67.0) 18.8 (3,850.8)
FINANCING ACTIVITIES      
Proceeds from long-term debt 0 0 3,476.3
Repayment of long-term debt (595.0) (265.0) 0
Payment of debt issuance costs (2.4) (9.4) (81.4)
Payment of contingent consideration 0 (43.0) (51.7)
Payment of deferred acquisition consideration (5.0) (1.6) (44.2)
Net proceeds from issuance of common stock pursuant to employee stock plans 81.4 75.1 28.6
Excess tax benefit related to equity awards 5.7 7.4 6.2
Payment of minimum tax withholdings on net share settlements of equity awards (9.8) (12.3) (5.7)
Net cash (used in) provided by financing activities (525.1) (248.8) 3,328.1
Effect of exchange rate changes on cash and cash equivalents (2.7) (1.7) 0.6
Net (decrease) increase in cash and cash equivalents (86.4) 262.1 (151.9)
Cash and cash equivalents, beginning of period 822.5 560.4 712.3
Cash and cash equivalents, end of period $ 736.1 $ 822.5 $ 560.4